| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | heparin binding | 1.15e-05 | 192 | 53 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.21e-05 | 323 | 53 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.35e-05 | 749 | 53 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.48e-05 | 268 | 53 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.40e-04 | 188 | 53 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 1.92e-04 | 8 | 53 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine phosphatase activity | 4.49e-04 | 12 | 53 | 2 | GO:0004726 | |
| GeneOntologyBiologicalProcess | epithelial cell-cell adhesion | 1.13e-05 | 18 | 51 | 3 | GO:0090136 | |
| MousePheno | abnormal response to injury | 1.53e-06 | 607 | 43 | 11 | MP:0005164 | |
| MousePheno | increased response of heart to induced stress | 2.04e-05 | 53 | 43 | 4 | MP:0004485 | |
| MousePheno | duplex kidney | 2.54e-05 | 19 | 43 | 3 | MP:0004017 | |
| MousePheno | biventricular, discordant atrioventricular connection | 2.77e-05 | 3 | 43 | 2 | MP:0011510 | |
| MousePheno | increased susceptibility to injury | 3.89e-05 | 208 | 43 | 6 | MP:0005165 | |
| MousePheno | abnormal blood vessel morphology | PCSK1 MED24 FAH SLIT2 THBS2 FBXW8 THBS4 PTPN12 DST RRM2B PRMT7 KIT CREBBP DNAH11 | 7.98e-05 | 1472 | 43 | 14 | MP:0001614 |
| MousePheno | cardiac fibrosis | 9.52e-05 | 151 | 43 | 5 | MP:0003141 | |
| MousePheno | absent endocochlear potential | 1.92e-04 | 7 | 43 | 2 | MP:0004410 | |
| MousePheno | superior-inferior ventricles | 1.92e-04 | 7 | 43 | 2 | MP:0011254 | |
| MousePheno | decreased vascular endothelial cell number | 2.56e-04 | 8 | 43 | 2 | MP:0006057 | |
| Domain | TSP_3 | 2.67e-10 | 5 | 52 | 4 | PF02412 | |
| Domain | TSP3 | 2.67e-10 | 5 | 52 | 4 | PS51234 | |
| Domain | TSP_CTER | 2.67e-10 | 5 | 52 | 4 | PS51236 | |
| Domain | - | 2.67e-10 | 5 | 52 | 4 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.67e-10 | 5 | 52 | 4 | IPR008859 | |
| Domain | TSP_C | 2.67e-10 | 5 | 52 | 4 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 2.67e-10 | 5 | 52 | 4 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 2.67e-10 | 5 | 52 | 4 | IPR003367 | |
| Domain | TSP_type-3_rpt | 2.67e-10 | 5 | 52 | 4 | IPR028974 | |
| Domain | Thbs/COMP_coiled-coil | 2.04e-08 | 3 | 52 | 3 | IPR024665 | |
| Domain | COMP | 2.04e-08 | 3 | 52 | 3 | PF11598 | |
| Domain | - | 2.49e-07 | 95 | 52 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 5.63e-07 | 58 | 52 | 5 | IPR001791 | |
| Domain | EGF_CA | 1.09e-06 | 122 | 52 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.20e-06 | 124 | 52 | 6 | IPR001881 | |
| Domain | ConA-like_dom | 2.37e-06 | 219 | 52 | 7 | IPR013320 | |
| Domain | EGF_3 | 3.77e-06 | 235 | 52 | 7 | PS50026 | |
| Domain | EGF | 3.77e-06 | 235 | 52 | 7 | SM00181 | |
| Domain | EGF_CA | 4.03e-06 | 86 | 52 | 5 | PF07645 | |
| Domain | EGF-like_dom | 5.52e-06 | 249 | 52 | 7 | IPR000742 | |
| Domain | EGF_1 | 6.45e-06 | 255 | 52 | 7 | PS00022 | |
| Domain | EGF_Ca-bd_CS | 7.30e-06 | 97 | 52 | 5 | IPR018097 | |
| Domain | EGF-like_CS | 7.51e-06 | 261 | 52 | 7 | IPR013032 | |
| Domain | EGF_CA | 8.06e-06 | 99 | 52 | 5 | PS01187 | |
| Domain | EGF_2 | 8.30e-06 | 265 | 52 | 7 | PS01186 | |
| Domain | TSPN | 3.47e-05 | 23 | 52 | 3 | SM00210 | |
| Domain | - | 1.13e-04 | 6 | 52 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 1.58e-04 | 7 | 52 | 2 | IPR001101 | |
| Domain | Plectin | 1.58e-04 | 7 | 52 | 2 | PF00681 | |
| Domain | PLEC | 1.58e-04 | 7 | 52 | 2 | SM00250 | |
| Domain | EGF | 4.16e-04 | 126 | 52 | 4 | PF00008 | |
| Domain | ATPase_dyneun-rel_AAA | 6.77e-04 | 14 | 52 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.77e-04 | 14 | 52 | 2 | PF07728 | |
| Domain | Growth_fac_rcpt_ | 9.28e-04 | 156 | 52 | 4 | IPR009030 | |
| Domain | TAS2R | 2.37e-03 | 26 | 52 | 2 | PF05296 | |
| Domain | T2R | 2.37e-03 | 26 | 52 | 2 | IPR007960 | |
| Domain | Spectrin_repeat | 2.94e-03 | 29 | 52 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.57e-03 | 32 | 52 | 2 | IPR018159 | |
| Domain | SPEC | 3.57e-03 | 32 | 52 | 2 | SM00150 | |
| Domain | PTPc | 4.51e-03 | 36 | 52 | 2 | SM00194 | |
| Domain | LAM_G_DOMAIN | 5.01e-03 | 38 | 52 | 2 | PS50025 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.27e-03 | 39 | 52 | 2 | PS50055 | |
| Domain | Laminin_G_2 | 5.54e-03 | 40 | 52 | 2 | PF02210 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 7.58e-06 | 86 | 45 | 5 | M2642 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.16e-05 | 57 | 45 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.39e-05 | 58 | 45 | 4 | M2049 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.45e-04 | 84 | 45 | 4 | M7098 | |
| Pathway | WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS | 1.48e-04 | 6 | 45 | 2 | M48303 | |
| Pubmed | 2.40e-11 | 5 | 53 | 4 | 30622267 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 3.35e-10 | 8 | 53 | 4 | 24460873 | |
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 3.34e-09 | 3 | 53 | 3 | 33910854 | |
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 1.34e-08 | 4 | 53 | 3 | 6338048 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 18467703 | ||
| Pubmed | GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells. | 2.28e-06 | 2 | 53 | 2 | 33554958 | |
| Pubmed | Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2. | 2.28e-06 | 2 | 53 | 2 | 16246837 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18684868 | ||
| Pubmed | Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. | 2.28e-06 | 2 | 53 | 2 | 11943589 | |
| Pubmed | Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. | 2.28e-06 | 2 | 53 | 2 | 27160021 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11137453 | ||
| Pubmed | Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. | 2.28e-06 | 2 | 53 | 2 | 10329465 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23875975 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 2.28e-06 | 2 | 53 | 2 | 30464261 | |
| Pubmed | Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. | 2.28e-06 | 2 | 53 | 2 | 17182969 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 9373030 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 15121769 | ||
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 6.83e-06 | 3 | 53 | 2 | 12482844 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 6.83e-06 | 3 | 53 | 2 | 26168731 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25976449 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 6.83e-06 | 3 | 53 | 2 | 1459996 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 6.83e-06 | 3 | 53 | 2 | 8400410 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 27633918 | ||
| Pubmed | Cdc42 is required for male germline niche development in mice. | 1.36e-05 | 4 | 53 | 2 | 34407418 | |
| Pubmed | Expression status of candidate genes in mesothelioma tissues and cell lines. | 1.36e-05 | 4 | 53 | 2 | 25771974 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.46e-05 | 31 | 53 | 3 | 31550482 | |
| Pubmed | 2.11e-05 | 35 | 53 | 3 | 35858542 | ||
| Pubmed | Cytogenetic characterization of radiosensitive mouse mutants. | 2.27e-05 | 5 | 53 | 2 | 1720867 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACTR1A PTPN12 MDN1 DST MBOAT7 DSP NIPSNAP1 PLEKHA5 HUWE1 CREBBP | 3.26e-05 | 1353 | 53 | 10 | 29467282 |
| Pubmed | 4.14e-05 | 418 | 53 | 6 | 34709266 | ||
| Pubmed | Sertoli cells are the source of stem cell factor for spermatogenesis. | 4.76e-05 | 7 | 53 | 2 | 36861441 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 5.17e-05 | 47 | 53 | 3 | 19167335 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 30185873 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 27934968 | ||
| Pubmed | Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. | 6.34e-05 | 8 | 53 | 2 | 17202846 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 16774856 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 12482924 | ||
| Pubmed | Isolation of novel mouse genes that were differentially expressed in W/W(V) mouse fundus. | 1.02e-04 | 10 | 53 | 2 | 15065000 | |
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 20301310 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 12802069 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 17903301 | ||
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 1.24e-04 | 11 | 53 | 2 | 27766308 | |
| Pubmed | 1.33e-04 | 1006 | 53 | 8 | 15226823 | ||
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 12189208 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 1.49e-04 | 12 | 53 | 2 | 12379855 | |
| Pubmed | Transcriptomic analysis of mouse limb tendon cells during development. | 1.49e-04 | 12 | 53 | 2 | 25249460 | |
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 26427057 | ||
| Pubmed | 1.52e-04 | 332 | 53 | 5 | 37433992 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 15938754 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 17936260 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 23457544 | ||
| Pubmed | Subcellular localization of intracellular protein tyrosine phosphatases in T cells. | 2.05e-04 | 14 | 53 | 2 | 10940933 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.15e-04 | 807 | 53 | 7 | 30575818 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 19762545 | ||
| Pubmed | 2.74e-04 | 591 | 53 | 6 | 15231748 | ||
| Pubmed | 2.95e-04 | 209 | 53 | 4 | 36779422 | ||
| Pubmed | 3.00e-04 | 210 | 53 | 4 | 16537572 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 3.05e-04 | 17 | 53 | 2 | 19727691 | |
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 3.05e-04 | 17 | 53 | 2 | 23502783 | |
| Pubmed | 3.09e-04 | 1139 | 53 | 8 | 36417873 | ||
| Pubmed | 3.13e-04 | 86 | 53 | 3 | 11044607 | ||
| Pubmed | Morphogenetic competence of HNF4 alpha-deficient mouse hepatic cells. | 3.43e-04 | 18 | 53 | 2 | 18617288 | |
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 3.83e-04 | 19 | 53 | 2 | 16799563 | |
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 16204234 | ||
| Pubmed | 4.11e-04 | 638 | 53 | 6 | 31182584 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 33397958 | ||
| Pubmed | 4.35e-04 | 645 | 53 | 6 | 25281560 | ||
| Pubmed | 4.52e-04 | 234 | 53 | 4 | 36243803 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 10761934 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 20227257 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 4.87e-04 | 100 | 53 | 3 | 25807483 | |
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 5.16e-04 | 22 | 53 | 2 | 12734386 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.18e-04 | 934 | 53 | 7 | 33916271 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 5.65e-04 | 23 | 53 | 2 | 10235267 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 5.65e-04 | 23 | 53 | 2 | 20022913 | |
| Pubmed | Reprogramming of Sertoli cells to fetal-like Leydig cells by Wt1 ablation. | 5.65e-04 | 23 | 53 | 2 | 25775596 | |
| Pubmed | 6.20e-04 | 963 | 53 | 7 | 28671696 | ||
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 6.68e-04 | 25 | 53 | 2 | 27340223 | |
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 12139982 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 7.23e-04 | 26 | 53 | 2 | 11696554 | |
| Pubmed | Deletion of the tyrosine phosphatase Shp2 in Sertoli cells causes infertility in mice. | 7.23e-04 | 26 | 53 | 2 | 26265072 | |
| Pubmed | 7.50e-04 | 268 | 53 | 4 | 33640491 | ||
| Pubmed | 7.57e-04 | 472 | 53 | 5 | 38943005 | ||
| Pubmed | 7.80e-04 | 27 | 53 | 2 | 12581520 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 8.40e-04 | 28 | 53 | 2 | 27002738 | |
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 8.40e-04 | 28 | 53 | 2 | 15744053 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 8.50e-04 | 1016 | 53 | 7 | 19056867 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.90e-04 | 1024 | 53 | 7 | 24711643 | |
| Pubmed | Prox2 and Runx3 vagal sensory neurons regulate esophageal motility. | 9.01e-04 | 29 | 53 | 2 | 37192624 | |
| Pubmed | 9.01e-04 | 29 | 53 | 2 | 17339028 | ||
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | 9.64e-04 | 30 | 53 | 2 | 17273929 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 9.64e-04 | 30 | 53 | 2 | 12679530 | |
| Pubmed | 9.80e-04 | 288 | 53 | 4 | 23383273 | ||
| Pubmed | 9.83e-04 | 754 | 53 | 6 | 35906200 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.26e-03 | 139 | 53 | 3 | 16985003 | |
| Pubmed | [IMAGE: molecular integration of the analysis of the human genome and its expression]. | 1.31e-03 | 35 | 53 | 2 | 7757816 | |
| Pubmed | 1.31e-03 | 35 | 53 | 2 | 28597972 | ||
| Pubmed | 1.37e-03 | 1431 | 53 | 8 | 37142655 | ||
| GeneFamily | EF-hand domain containing|Plakins | 1.07e-04 | 8 | 36 | 2 | 939 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 5.78e-04 | 18 | 36 | 2 | 812 | |
| GeneFamily | Taste 2 receptors | 2.73e-03 | 39 | 36 | 2 | 1162 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 3.51e-05 | 455 | 53 | 7 | MM1189 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 4.21e-05 | 191 | 53 | 5 | M40019 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.21e-05 | 191 | 53 | 5 | MM17059 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 4.67e-05 | 98 | 53 | 4 | M40018 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.76e-05 | 196 | 53 | 5 | M3008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.94e-05 | 856 | 53 | 9 | M4500 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP | 5.24e-05 | 200 | 53 | 5 | M9169 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 9.36e-05 | 721 | 53 | 8 | M1999 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 9.96e-08 | 193 | 52 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-07 | 197 | 52 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 188 | 52 | 5 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 189 | 52 | 5 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 193 | 52 | 5 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 197 | 52 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-06 | 200 | 52 | 5 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 2.35e-05 | 143 | 52 | 4 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-05 | 166 | 52 | 4 | da10d0be6b616199d49dd922591c2901f9681583 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 169 | 52 | 4 | 780fb0050852626062a729dd1b82b0cf61e7e9ca | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 176 | 52 | 4 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 180 | 52 | 4 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.90e-05 | 181 | 52 | 4 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.90e-05 | 181 | 52 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.90e-05 | 181 | 52 | 4 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-05 | 186 | 52 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 186 | 52 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.69e-05 | 187 | 52 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-05 | 190 | 52 | 4 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.12e-05 | 190 | 52 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.27e-05 | 191 | 52 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.27e-05 | 191 | 52 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.56e-05 | 193 | 52 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.56e-05 | 193 | 52 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 7.56e-05 | 193 | 52 | 4 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.72e-05 | 194 | 52 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.72e-05 | 194 | 52 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 195 | 52 | 4 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.87e-05 | 195 | 52 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.87e-05 | 195 | 52 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.87e-05 | 195 | 52 | 4 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | hematopoetic_progenitors-CD34+_MPP|World / Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | 851064ca1ab727b4972ad4b72234ee130998a799 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.87e-05 | 195 | 52 | 4 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-05 | 196 | 52 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 52 | 4 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 52 | 4 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 196 | 52 | 4 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 8.03e-05 | 196 | 52 | 4 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-05 | 196 | 52 | 4 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 196 | 52 | 4 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 8.03e-05 | 196 | 52 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 52 | 4 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-05 | 196 | 52 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.19e-05 | 197 | 52 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.19e-05 | 197 | 52 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 197 | 52 | 4 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 8.19e-05 | 197 | 52 | 4 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.19e-05 | 197 | 52 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.35e-05 | 198 | 52 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-05 | 198 | 52 | 4 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.35e-05 | 198 | 52 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.35e-05 | 198 | 52 | 4 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.35e-05 | 198 | 52 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 198 | 52 | 4 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.35e-05 | 198 | 52 | 4 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.35e-05 | 198 | 52 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.51e-05 | 199 | 52 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 8.51e-05 | 199 | 52 | 4 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-05 | 199 | 52 | 4 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 8.51e-05 | 199 | 52 | 4 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 8.51e-05 | 199 | 52 | 4 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.51e-05 | 199 | 52 | 4 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 199 | 52 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 8.51e-05 | 199 | 52 | 4 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 199 | 52 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.68e-05 | 200 | 52 | 4 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.68e-05 | 200 | 52 | 4 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.68e-05 | 200 | 52 | 4 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 8.68e-05 | 200 | 52 | 4 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.54e-04 | 118 | 52 | 3 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.59e-04 | 129 | 52 | 3 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.47e-04 | 137 | 52 | 3 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-04 | 150 | 52 | 3 | 42fd42a0be918a77aca4e0c91f068bdd5a5d9286 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-04 | 150 | 52 | 3 | 909ccab92855f5f049dc29593aadab1ea973297b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-04 | 150 | 52 | 3 | c2fcdd62ec85cbf9783a525cd7556e16a1e55cd8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-04 | 150 | 52 | 3 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.69e-04 | 154 | 52 | 3 | 835ef49d314ecbcbfd8d1041ba202a5eedcda0bd | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 157 | 52 | 3 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | Control-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.13e-04 | 157 | 52 | 3 | 4803f601c1ba43260aa09172acc7964aac2c8ccf | |
| ToppCell | Control-B_naive-12|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.28e-04 | 158 | 52 | 3 | 41318f864770370ce77ed3fa4a84f76c0c22c482 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 8.43e-04 | 159 | 52 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.43e-04 | 159 | 52 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-04 | 159 | 52 | 3 | 3bab00f8fb7d9232538e50f83dd0fd70ddd16819 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 3.42e-05 | 37 | 50 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 1.07e-04 | 54 | 50 | 3 | C0149925 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.26e-04 | 10 | 50 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.53e-04 | 14 | 50 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | hyperglycemia (implicated_via_orthology) | 3.77e-04 | 17 | 50 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.96e-04 | 84 | 50 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.72e-04 | 19 | 50 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | granulocyte count | 9.05e-04 | 254 | 50 | 4 | EFO_0007987 | |
| Disease | body weight | 1.18e-03 | 1261 | 50 | 8 | EFO_0004338 | |
| Disease | joint hypermobility measurement | 1.44e-03 | 33 | 50 | 2 | EFO_0007905 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EWTQLDMFYRNWALK | 166 | Q9NRN7 | |
| NTWAEMYRNRYWKEH | 226 | O95154 | |
| VVMWKQMEQTYWQAN | 611 | P49747 | |
| TSKPMYRRWWEQFVQ | 226 | O75909 | |
| DVWLMFNNAWLYNRK | 1156 | Q92793 | |
| LMFSDSGWNWKQYRQ | 111 | Q9C0A0 | |
| YQADFSRWWQKEMKA | 2426 | Q96DT5 | |
| NTYRDFWLMVWEQKV | 381 | P43378 | |
| SWEVQRFDGWYNNLM | 26 | Q9NRD9 | |
| RATNQDWMLRVKWLY | 2526 | Q9NU22 | |
| YLKDLWTTFIDMQWR | 51 | P78508 | |
| QQWIYMNRTFTDKWE | 346 | P10721 | |
| LKWMYSTAAQQHQWD | 201 | P43220 | |
| IEAYRAAMQTQWSWI | 776 | Q03001 | |
| LVSVWDYRMNQKLWE | 496 | Q8N3Y1 | |
| NQNSQVEWKYIWSTM | 56 | A6NFY4 | |
| NMTVQWWLAQYIYKS | 321 | Q96N66 | |
| ISDWLYVQKMNTWFK | 251 | O60774 | |
| TFEKRYAAAMQWLWR | 126 | P30679 | |
| MTKYLQSNSNNWRWF | 1606 | Q7Z6Z7 | |
| MEEYRTSLQQWKAWR | 571 | Q9P2K1 | |
| YAQLVESGRMWSWNK | 181 | Q9NVM4 | |
| KIEAYMDTLQTQWSW | 346 | P15924 | |
| DYQFWMQKLSVWDQA | 11 | Q00597 | |
| KDWNDMERIWQYVYS | 81 | P61163 | |
| NLESVMNWQQYWKDE | 126 | Q86W47 | |
| MNDWSARDIQKWEYV | 231 | P16930 | |
| LWQKVDDRFFWNKYM | 201 | Q9Y2H2 | |
| QESYVWKMYQERCWE | 4936 | Q92736 | |
| KRQQWQWIDGAMYLY | 101 | Q9BYZ8 | |
| TMIEWGNNWARAIKY | 196 | Q9BPW8 | |
| QIVWTKEYEGNMTWK | 151 | P59539 | |
| QIIWTKEYEGNMTWK | 151 | P59540 | |
| LQQDWRSMQLDYTTW | 641 | Q96R06 | |
| ERWSDYQWAINMKKF | 16 | O75448 | |
| ANTVIDFWRMIWEYN | 111 | Q05209 | |
| MTTSFWKRRNWYVDD | 161 | Q9NZE8 | |
| VVMQWSYQEAWNSLL | 251 | Q6P1J6 | |
| YRWMRRSQENQWQKE | 176 | Q3YBM2 | |
| DIWKMYKQAQASFWT | 51 | Q7LG56 | |
| ESWGNNMVVRVKWFY | 2846 | O15417 | |
| VMWKQTEQTYWQATP | 811 | P35443 | |
| WSYFSQVQEIMWTFN | 106 | P06133 | |
| WGQRWYQKEFAQEMT | 526 | Q6UWL2 | |
| TRLFWWYHTMANQQV | 341 | Q86VZ5 | |
| NMQWLSDWVKSEYKE | 866 | O94813 | |
| VVMWKQTEQTYWQAT | 806 | P49746 | |
| MWKQVTQTYWEDQPT | 1041 | P35442 | |
| RDDTMWQLYEWQQRQ | 496 | Q9HAU0 | |
| VMWENYTNVMSVENW | 31 | Q9UL59 | |
| VQVTENEDWNFYWMS | 26 | O95922 | |
| NEDWNFYWMSVQTIR | 31 | O95922 | |
| IQETQMKYLSEWDQW | 106 | Q7Z402 | |
| WNQQWYLQDTRMTAA | 126 | P29120 |